Global Influenza Treatment Market Research Report 2025(Status and Outlook)

March 2025 | 205 pages | ID: G4BCFFCC8740EN
Bosson Research

Abstracts

Report Overview

Flu, also called influenza, is an infection of the nose, throat and lungs, which are part of the respiratory system. The flu is caused by a virus.

This report provides a deep insight into the global Influenza Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Treatment market in any manner.

Global Influenza Treatment Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis AG

Roche Holding

BioCryst Pharmaceuticals

Sanofi

GSK plc.

Viatris Inc. (Mylan)

Teva Pharmaceutical Industries Ltd.

Daiichi Sankyo

AstraZeneca

NATCO Pharma Limited

Gilead Sciences

Market Segmentation (by Type)

Peramivir

Zanamivir

Baloxavir Marboxil

Oseltamivir Phosphate

Others

Market Segmentation (by Application)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Treatment Market
• Overview of the regional outlook of the Influenza Treatment Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Treatment
1.2 Key Market Segments
1.2.1 Influenza Treatment Segment by Type
1.2.2 Influenza Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Influenza Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Treatment Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Influenza Treatment Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Influenza Treatment Product Life Cycle
3.3 Global Influenza Treatment Sales by Manufacturers (2020-2025)
3.4 Global Influenza Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Influenza Treatment Manufacturing Sites, Area Served, Product Type
3.8 Influenza Treatment Market Competitive Situation and Trends
3.8.1 Influenza Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Influenza Treatment Industry Chain Analysis
4.1 Influenza Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Treatment Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Influenza Treatment Market
5.7 ESG Ratings of Leading Companies
6 Global Influenza Treatment Market by Region
6.1 Global Influenza Treatment Market Size by Region
6.1.1 Global Influenza Treatment Market Size by Region
6.1.2 Global Influenza Treatment Market Size Market Share by Region
6.2 Global Influenza Treatment Sales by Region
6.2.1 Global Influenza Treatment Sales by Region
6.2.2 Global Influenza Treatment Sales Market Share by Region
7 North America Market Overview
7.1 North America Influenza Treatment Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Influenza Treatment Market Size by Type
7.3 North America Influenza Treatment Market Size by Application
8 Europe Market Overview
8.1 Europe Influenza Treatment Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Influenza Treatment Market Size by Type
8.3 Europe Influenza Treatment Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Influenza Treatment Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Influenza Treatment Market Size by Type
9.3 Asia-Pacific Influenza Treatment Market Size by Application
10 South America Market Overview
10.1 South America Influenza Treatment Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Influenza Treatment Market Size by Type
10.3 South America Influenza Treatment Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Influenza Treatment Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Influenza Treatment Market Size by Type
11.3 Middle East and Africa Influenza Treatment Market Size by Application
12 Influenza Treatment Market Production by Region
12.1 Global Production of Influenza Treatment by Region(2020-2025)
12.2 Global Influenza Treatment Revenue Market Share by Region (2020-2025)
12.3 Global Influenza Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Influenza Treatment Production
12.4.1 North America Influenza Treatment Production Growth Rate (2020-2025)
12.4.2 North America Influenza Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Influenza Treatment Production
12.5.1 Europe Influenza Treatment Production Growth Rate (2020-2025)
12.5.2 Europe Influenza Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Influenza Treatment Production (2020-2025)
12.6.1 Japan Influenza Treatment Production Growth Rate (2020-2025)
12.6.2 Japan Influenza Treatment Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Influenza Treatment Production (2020-2025)
12.7.1 China Influenza Treatment Production Growth Rate (2020-2025)
12.7.2 China Influenza Treatment Production, Revenue, Price and Gross Margin (2020-2025)
13 Influenza Treatment Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Influenza Treatment Sales Market Share by Type (2020-2033)
13.3 Global Influenza Treatment Market Size Market Share by Type (2020-2033)
13.4 Global Influenza Treatment Price by Type (2020-2033)
14 Influenza Treatment Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Influenza Treatment Market Sales by Application (2020-2033)
14.3 Global Influenza Treatment Market Size (M USD) by Application (2020-2033)
14.4 Global Influenza Treatment Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Novartis AG
15.1.1 Novartis AG Basic Information
15.1.2 Novartis AG Influenza Treatment Product Overview
15.1.3 Novartis AG Influenza Treatment Product Market Performance
15.1.4 Novartis AG Business Overview
15.1.5 Novartis AG SWOT Analysis
15.1.6 Novartis AG Recent Developments
15.2 Roche Holding
15.2.1 Roche Holding Basic Information
15.2.2 Roche Holding Influenza Treatment Product Overview
15.2.3 Roche Holding Influenza Treatment Product Market Performance
15.2.4 Roche Holding Business Overview
15.2.5 Roche Holding SWOT Analysis
15.2.6 Roche Holding Recent Developments
15.3 BioCryst Pharmaceuticals
15.3.1 BioCryst Pharmaceuticals Basic Information
15.3.2 BioCryst Pharmaceuticals Influenza Treatment Product Overview
15.3.3 BioCryst Pharmaceuticals Influenza Treatment Product Market Performance
15.3.4 BioCryst Pharmaceuticals Business Overview
15.3.5 BioCryst Pharmaceuticals SWOT Analysis
15.3.6 BioCryst Pharmaceuticals Recent Developments
15.4 Sanofi
15.4.1 Sanofi Basic Information
15.4.2 Sanofi Influenza Treatment Product Overview
15.4.3 Sanofi Influenza Treatment Product Market Performance
15.4.4 Sanofi Business Overview
15.4.5 Sanofi Recent Developments
15.5 GSK plc.
15.5.1 GSK plc. Basic Information
15.5.2 GSK plc. Influenza Treatment Product Overview
15.5.3 GSK plc. Influenza Treatment Product Market Performance
15.5.4 GSK plc. Business Overview
15.5.5 GSK plc. Recent Developments
15.6 Viatris Inc. (Mylan)
15.6.1 Viatris Inc. (Mylan) Basic Information
15.6.2 Viatris Inc. (Mylan) Influenza Treatment Product Overview
15.6.3 Viatris Inc. (Mylan) Influenza Treatment Product Market Performance
15.6.4 Viatris Inc. (Mylan) Business Overview
15.6.5 Viatris Inc. (Mylan) Recent Developments
15.7 Teva Pharmaceutical Industries Ltd.
15.7.1 Teva Pharmaceutical Industries Ltd. Basic Information
15.7.2 Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Overview
15.7.3 Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Market Performance
15.7.4 Teva Pharmaceutical Industries Ltd. Business Overview
15.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
15.8 Daiichi Sankyo
15.8.1 Daiichi Sankyo Basic Information
15.8.2 Daiichi Sankyo Influenza Treatment Product Overview
15.8.3 Daiichi Sankyo Influenza Treatment Product Market Performance
15.8.4 Daiichi Sankyo Business Overview
15.8.5 Daiichi Sankyo Recent Developments
15.9 AstraZeneca
15.9.1 AstraZeneca Basic Information
15.9.2 AstraZeneca Influenza Treatment Product Overview
15.9.3 AstraZeneca Influenza Treatment Product Market Performance
15.9.4 AstraZeneca Business Overview
15.9.5 AstraZeneca Recent Developments
15.10 NATCO Pharma Limited
15.10.1 NATCO Pharma Limited Basic Information
15.10.2 NATCO Pharma Limited Influenza Treatment Product Overview
15.10.3 NATCO Pharma Limited Influenza Treatment Product Market Performance
15.10.4 NATCO Pharma Limited Business Overview
15.10.5 NATCO Pharma Limited Recent Developments
15.11 Gilead Sciences
15.11.1 Gilead Sciences Basic Information
15.11.2 Gilead Sciences Influenza Treatment Product Overview
15.11.3 Gilead Sciences Influenza Treatment Product Market Performance
15.11.4 Gilead Sciences Business Overview
15.11.5 Gilead Sciences Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Treatment Market Size by Type (M USD)
Table 4. Global Influenza Treatment Market Size by Application (M USD)
Table 5. Influenza Treatment Market Size Comparison by Region (M USD)
Table 6. Global Influenza Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Treatment as of 2024)
Table 11. Global Market Influenza Treatment Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Influenza Treatment Manufacturing Sites and Area Served
Table 13. Manufacturers Influenza Treatment Product Type
Table 14. Global Influenza Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Influenza Treatment Market Size Comparison by Region (M USD)
Table 26. Global Influenza Treatment Market Size by Region (2020-2033) & (M USD)
Table 27. Global Influenza Treatment Market Size Market Share by Region (2020-2033)
Table 28. Global Influenza Treatment Sales by Region (2020-2033) & (K MT)
Table 29. Global Influenza Treatment Sales Market Share by Region (2020-2033)
Table 30. North America Influenza Treatment Market Size by Country (2020-2033) & (M USD)
Table 31. North America Influenza Treatment Sales by Country (2020-2033) & (K MT)
Table 32. North America Influenza Treatment Sales by Type (K MT)
Table 33. North America Influenza Treatment Market Size by Type (M USD)
Table 34. North America Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 35. North America Influenza Treatment Market Size (M USD) by Type (2020-2033)
Table 36. North America Influenza Treatment Sales by Application (K MT)
Table 37. North America Influenza Treatment Market Size by Application (M USD)
Table 38. North America Influenza Treatment Sales (K MT) by Application (2020-2033)
Table 39. North America Influenza Treatment Market Size (M USD) by Application (2020-2033)
Table 40. Europe Influenza Treatment Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Influenza Treatment Sales by Country (2020-2033) & (K MT)
Table 42. Europe Influenza Treatment Sales by Type (K MT)
Table 43. Europe Influenza Treatment Market Size by Type (M USD)
Table 44. Europe Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 45. Europe Influenza Treatment Market Size (M USD) by Type (2020-2033)
Table 46. Europe Influenza Treatment Sales by Application (K MT)
Table 47. Europe Influenza Treatment Market Size by Application (M USD)
Table 48. Europe Influenza Treatment Sales (K MT) by Application (2020-2033)
Table 49. Europe Influenza Treatment Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Influenza Treatment Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Influenza Treatment Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Influenza Treatment Sales by Type (K MT)
Table 53. Asia-Pacific Influenza Treatment Market Size by Type (M USD)
Table 54. Asia-Pacific Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Influenza Treatment Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Influenza Treatment Sales by Application (K MT)
Table 57. Asia-Pacific Influenza Treatment Market Size by Application (M USD)
Table 58. Asia-Pacific Influenza Treatment Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Influenza Treatment Market Size (M USD) by Application (2020-2025)
Table 60. South America Influenza Treatment Market Size by Country (2020-2033) & (M USD)
Table 61. South America Influenza Treatment Sales by Country (2020-2033) & (K MT)
Table 62. South America Influenza Treatment Sales by Type (K MT)
Table 63. South America Influenza Treatment Market Size by Type (M USD)
Table 64. South America Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 65. South America Influenza Treatment Market Size (M USD) by Type (2020-2033)
Table 66. South America Influenza Treatment Sales by Application (K MT)
Table 67. South America Influenza Treatment Market Size by Application (M USD)
Table 68. South America Influenza Treatment Sales (K MT) by Application (2020-2033)
Table 69. South America Influenza Treatment Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Influenza Treatment Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Influenza Treatment Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Influenza Treatment Sales by Type (K MT)
Table 73. Middle East and Africa Influenza Treatment Market Size by Type (M USD)
Table 74. Middle East and Africa Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Influenza Treatment Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Influenza Treatment Sales by Application (K MT)
Table 77. Middle East and Africa Influenza Treatment Market Size by Application (M USD)
Table 78. Middle East and Africa Influenza Treatment Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Influenza Treatment Market Size (M USD) by Application (2020-2033)
Table 80. Global Influenza Treatment Production (K MT) by Region(2020-2025)
Table 81. Global Influenza Treatment Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Influenza Treatment Revenue Market Share by Region (2020-2025)
Table 83. Global Influenza Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Influenza Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Influenza Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Influenza Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Influenza Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Influenza Treatment Sales by Type (K MT)
Table 89. Global Influenza Treatment Market Size by Type (M USD)
Table 90. Global Influenza Treatment Sales (K MT) by Type (2020-2033)
Table 91. Global Influenza Treatment Sales Market Share by Type (2020-2033)
Table 92. Global Influenza Treatment Market Size (M USD) by Type (2020-2033)
Table 93. Global Influenza Treatment Market Size Share by Type (2020-2033)
Table 94. Global Influenza Treatment Sales (K MT) by Application
Table 95. Global Influenza Treatment Market Size by Application(M USD)
Table 96. Global Influenza Treatment Sales by Application (2020-2033) & (K MT)
Table 97. Global Influenza Treatment Sales Market Share by Application (2020-2033)
Table 98. Global Influenza Treatment Market Size by Application (2020-2033) & (M USD)
Table 99. Global Influenza Treatment Market Share by Application (2020-2033)
Table 100. Global Influenza Treatment Sales Growth Rate by Application (2020-2033)
Table 101. Novartis AG Basic Information
Table 102. Novartis AG Influenza Treatment Product Overview
Table 103. Novartis AG Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Novartis AG Business Overview
Table 105. Novartis AG SWOT Analysis
Table 106. Novartis AG Recent Developments
Table 107. Roche Holding Basic Information
Table 108. Roche Holding Influenza Treatment Product Overview
Table 109. Roche Holding Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Roche Holding Business Overview
Table 111. Roche Holding SWOT Analysis
Table 112. Roche Holding Recent Developments
Table 113. BioCryst Pharmaceuticals Basic Information
Table 114. BioCryst Pharmaceuticals Influenza Treatment Product Overview
Table 115. BioCryst Pharmaceuticals Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. BioCryst Pharmaceuticals Business Overview
Table 117. BioCryst Pharmaceuticals SWOT Analysis
Table 118. BioCryst Pharmaceuticals Recent Developments
Table 119. Sanofi Basic Information
Table 120. Sanofi Influenza Treatment Product Overview
Table 121. Sanofi Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Sanofi Business Overview
Table 123. Sanofi Recent Developments
Table 124. GSK plc. Basic Information
Table 125. GSK plc. Influenza Treatment Product Overview
Table 126. GSK plc. Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. GSK plc. Business Overview
Table 128. GSK plc. Recent Developments
Table 129. Viatris Inc. (Mylan) Basic Information
Table 130. Viatris Inc. (Mylan) Influenza Treatment Product Overview
Table 131. Viatris Inc. (Mylan) Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Viatris Inc. (Mylan) Business Overview
Table 133. Viatris Inc. (Mylan) Recent Developments
Table 134. Teva Pharmaceutical Industries Ltd. Basic Information
Table 135. Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Overview
Table 136. Teva Pharmaceutical Industries Ltd. Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Teva Pharmaceutical Industries Ltd. Business Overview
Table 138. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 139. Daiichi Sankyo Basic Information
Table 140. Daiichi Sankyo Influenza Treatment Product Overview
Table 141. Daiichi Sankyo Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Daiichi Sankyo Business Overview
Table 143. Daiichi Sankyo Recent Developments
Table 144. AstraZeneca Basic Information
Table 145. AstraZeneca Influenza Treatment Product Overview
Table 146. AstraZeneca Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. AstraZeneca Business Overview
Table 148. AstraZeneca Recent Developments
Table 149. NATCO Pharma Limited Basic Information
Table 150. NATCO Pharma Limited Influenza Treatment Product Overview
Table 151. NATCO Pharma Limited Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. NATCO Pharma Limited Business Overview
Table 153. NATCO Pharma Limited Recent Developments
Table 154. Gilead Sciences Basic Information
Table 155. Gilead Sciences Influenza Treatment Product Overview
Table 156. Gilead Sciences Influenza Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Gilead Sciences Business Overview
Table 158. Gilead Sciences Recent Developments
List of Figures
Figure 1. Product Picture of Influenza Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Treatment Market Size (M USD), 2024-2033
Figure 5. Global Influenza Treatment Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Treatment Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Treatment Product Life Cycle
Figure 13. Influenza Treatment Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Treatment Revenue Share by Manufacturers in 2024
Figure 15. Influenza Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Treatment Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Treatment Revenue in 2024
Figure 18. Industry Chain Map of Influenza Treatment
Figure 19. Global Influenza Treatment Market PEST Analysis
Figure 20. Global Influenza Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Influenza Treatment Market Size by Region
Figure 27. Global Influenza Treatment Market Size Market Share by Region (2020-2033)
Figure 28. Global Influenza Treatment Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Influenza Treatment Market Size (M USD) by Country
Figure 33. USA Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Influenza Treatment Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Influenza Treatment Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Influenza Treatment Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Influenza Treatment Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Influenza Treatment Market Size (M USD)by Type
Figure 40. North America Influenza Treatment Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Influenza Treatment Market Size (M USD) by Country
Figure 45. Germany Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Influenza Treatment Market Size (M USD) by Type
Figure 56. Europe Influenza Treatment Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Influenza Treatment Market Size (M USD) by Country
Figure 61. China Influenza Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Influenza Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Influenza Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Influenza Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Influenza Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Influenza Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Influenza Treatment Market Size (M USD) by Type
Figure 72. Asia-Pacific Influenza Treatment Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Influenza Treatment Market Size (M USD) by Country
Figure 77. Brazil Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Influenza Treatment Market Size (M USD) by Type
Figure 84. South America Influenza Treatment Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Influenza Treatment Market Size (M USD) by Country
Figure 89. Saudi Arabia Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Influenza Treatment Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Influenza Treatment Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Influenza Treatment Market Size (M USD) by Type
Figure 100. Middle East and Africa Influenza Treatment Market Size (M USD) by Application
Figure 101. Global Influenza Treatment Production Market Share by Region (2020-2025)
Figure 102. North America Influenza Treatment Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Influenza Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Influenza Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. China Influenza Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Influenza Treatment Market Size by Type (M USD)
Figure 108. Sales Market Share of Influenza Treatment by Type (2020-2033)
Figure 109. Sales Market Share of Influenza Treatment by Type in 2024
Figure 110. Market Size Share of Influenza Treatment by Type (2020-2033)
Figure 111. Market Size Share of Influenza Treatment by Type in 2024
Figure 112. Global Influenza Treatment Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Influenza Treatment Market Size by Application(M USD)
Figure 115. Global Influenza Treatment Market Share by Application
Figure 116. Global Influenza Treatment Sales Market Share by Application (2020-2033)
Figure 117. Global Influenza Treatment Sales Market Share by Application in 2024
Figure 118. Global Influenza Treatment Market Share by Application (2020-2033)
Figure 119. Global Influenza Treatment Market Share by Application in 2024
Figure 120. Global Influenza Treatment Sales Growth Rate by Application (2020-2033)